(Q46856164)

25 December 2017

title

Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn's disease (English)

1 reference

25 December 2017

author name string

Anurag Agrawal

1

1 reference

25 December 2017

Shireen Durrani

2

1 reference

25 December 2017

Keith Leiper

3

1 reference

25 December 2017

Anthony Ellis

4

1 reference

25 December 2017

Anthony I Morris

5

1 reference

25 December 2017

Jonathan M Rhodes

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

25 December 2017

Clinical Gastroenterology and Hepatology

published in

1 reference

25 December 2017

volume

3

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

1215-1220

1 reference

25 December 2017

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Chronic inflammatory bowel disease in glycogen storage disease type 1B

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Mucosal flora in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Application of the Vienna Classification for Crohn's disease to a single clinician database of 877 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activity

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Molecular evidence for two forms of Crohn disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Long-term evolution of disease behavior of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Smoking in Crohn's disease: effect on localisation and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Risk factors for intra-abdominal sepsis after surgery in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Risk factors for early postoperative recurrence of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

A simple index of Crohn's-disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Effects of Corticosteroid Therapy on Human Monocyte Function

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

6-Mercaptopurine is effective in Crohn's disease without concomitant steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900759-7

7 January 2021

10.1016/S1542-3565(05)00759-7

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017